Printer Friendly

ANALYST INTERVIEW: SMALL CAP BIOTECHNOLOGY COMPANIES: RUSSELL GILBERTSON - ROTH CAPITAL PARTNERS LLC.

(TAD800) SMALL CAP BIOTECHNOLOGY COMPANIES: RUSSELL GILBERTSON - ROTH CAPITAL PARTNERS LLC. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 7/28/03. Tickers featured: AMGN, AMLN, AVGN, DNA, IDBE, ISIS, LGND, LLY, MAXM, MEDI, NABI, VVUS. Complete text approximately 3000 words. Document # TAD800.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: information@twst.com.

***
COPYRIGHT 2003 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Wall Street Transcript Digest
Article Type:Brief Article
Geographic Code:1USA
Date:Jul 28, 2003
Words:109
Previous Article:ANALYST INTERVIEW: THERAPEUTICS-BASED COMPANIES: MARK SCHOENEBAUM - U.S. BANCORP PIPER JAFFRAY INC.
Next Article:OFF THE RECORD: BIOTECHNOLOGY.
Topics:


Related Articles
ANALYST INTERVIEW: OUTLOOK FOR BIOTECHNOLOGY STOCKS: FARIBA GHODSIAN - ROTH CAPITAL PARTNERS.
ANALYST INTERVIEW: OUTLOOK FOR BIOTECHNOLOGY: FARIBA GHODSIAN - ROTH CAPITAL PARTNERS.
ANALYST INTERVIEW: FUNDING BIOTECH COMPANIES: FARIBA GHODSIAN - ROTH CAPITAL PARTNERS.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters